by Impulse Dynamics | May 13, 2016 | Press Releases
Mt. Laurel, New Jersey, May 13 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30 million financing round. The equity financing round was led by...
by Impulse Dynamics | Mar 1, 2016 | Press Releases
Stuttgart, Germany, March 2016 – Impulse Dynamics announced the first two implantations of its Optimizer IVs device in Slovenia. The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). The device is based on...
by Impulse Dynamics | Jan 11, 2016 | Press Releases
Hong Kong, China – January 11th, 2016 – Impulse Dynamics NV (Impulse), the developer of the Optimizer™ IVs implantable device, is pleased to announce the official opening of its Hong Kong sales and support office. The Optimizer IVs is a minimally invasive implantable...
by Impulse Dynamics | Nov 11, 2015 | Press Releases
Stuttgart, Germany, November 11th, 2015 – Impulse Dynamics reported today the first implantation of its Optimizer IVs device in the Emirate of Sharjah (UAE). The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF)....
by Impulse Dynamics | Aug 13, 2015 | Press Releases
Stuttgart, Germany – August 13th, 2015 – Impulse Dynamics announced today (13 August, 2015) the first implantation of its Optimizer IVs device in Poland, at the University Hospital – Central Veterans’ Hospital in Lodz. The implantation was performed by Dr. Krzysztof...
